University of Washington-Seattle Campus · Engineering · Biomedical EngineeringStayton Lab
Patrick S. Stayton · Seattle, Washington
Research Focus
Dr. Patrick S. Stayton's lab focuses on developing innovative therapies for respiratory infections, particularly those caused by coronaviruses and antibiotic-resistant bacteria. By utilizing advanced biomaterials and drug delivery systems, the lab aims to create inhalable treatments that can target lung infections effectively and improve outcomes for patients, especially in crises like pandemics. Their research seeks to revolutionize how we combat pulmonary pathogens through targeted drug delivery and combination therapies.
COVID-19pulmonary infectionsinhalation therapydrug deliveryantibiotic resistancepolymeric prodrugshost-directed therapynebulizersbacterial infections
Research Aims
4AIM 01Develop inhalable therapeutic platforms targeting respiratory infections.
AIM 02Create combination therapies for antibiotic-resistant bacterial infections.
AIM 03Optimize drug delivery to lung macrophages for sustained efficacy.
AIM 04Investigate immune-modulatory strategies alongside traditional antibiotics.
Skills the Lab Values
cell cultureanimal modelsinhalation drug administrationdrug formulationpharmacokineticsimmune modulationmicroscopybiomedical device developmentmicrobiologyresearch design
Output against the department
Publications355top 24% of dept.209th of 868
this lab
most publishedleast published
Citations23ktop 14% of dept.124th of 868
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.